Corient Private Wealth
MGNX icon

Corient Private Wealth’s MacroGenics MGNX Stock Holding History

Corient Private Wealth’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$92K Buy
31,820
+8,176
+35% +$17.4K ﹤0.01% 2704
2025
Q4 		$38.1K Buy
23,644
+9,020
+62% +$14.2K ﹤0.01% 2687
2025
Q3 		$24.6K Buy
+14,624
New +$23.7K ﹤0.01% 2524
2023
Q4 		– Sell
-11,738
Closed -$54.7K – 2316
2023
Q3 		$54.7K Hold
11,738
– – ﹤0.01% 2072
2023
Q2 		$62.8K Buy
+11,738
New +$72.4K ﹤0.01% 2007

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Corient Private Wealth's MGNX Position: Q1 2026 in Review

Corient Private Wealth increased its MacroGenics (MGNX) stake by 35% in Q1 2026, buying an estimated $17.4K and bringing the position to 31,820 shares worth $92K. The position accounts for ﹤0.01% of the portfolio, ranked #2704.

Corient Private Wealth first reported a position in MGNX in Q2 2023 and has held it in 5 quarters since. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Corient Private Wealth held 31,820 shares of MacroGenics worth $92K as of Q1 2026.
  • Corient Private Wealth bought 8,176 MacroGenics shares in Q1 2026, an estimated $17.4K.
  • MacroGenics made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2704 holding.
  • Corient Private Wealth first reported a position in MacroGenics in Q2 2023 and has held it in 5 quarters since.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.